Dynamic ASPECTS of Internal PRE-ACTIVATION of Effects Sensors of Voluntary ACTION in PARKINSON's Disease
DYNIDEO
The Impact of Parkinson's Disease on Internal Preactivation of Sensory Effects of Intention-based Actions. A Subliminal Priming Study
1 other identifier
observational
28
1 country
1
Brief Summary
The ability to predict sensory effects of people's own motor actions is a key component of Human action realization. Recent studies revealed this anticipation process to be involved in early and late stages of voluntary actions. Nevertheless, the question whether the action-effect anticipation is impacted or not by "motor pathologies", such as the Parkinson's disease, remains unclear. The current study is aimed to clarify this issue by using a subliminal priming paradigm in patients with Parkinson's disease and in matched control participants. Indeed, subliminal primes corresponding to visual action-effects are displayed at different time points before the actions' execution. Results should allow to determine whether or not the action-effect prediction is impaired at different stages of voluntary action in patients with Parkinson's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2015
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 5, 2016
CompletedFirst Posted
Study publicly available on registry
September 9, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedAugust 31, 2018
August 1, 2018
1.3 years
September 5, 2016
August 30, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Reaction time
time measured in seconds
baseline
error rate
baseline
Study Arms (2)
Parkinson's disease
Healthy subjects
gender and age matched with Parkinson's disease patients, whose data will be extracted from an existing database
Interventions
Eligibility Criteria
patients with Parkinson's disease, according to the MDS-UPDRS III (Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale), matched for gender and for age with healthy subjects from a database. This database has already been constituted by the CNRS (Centre national de la recherche scientifique, Laboratory of Psychology of Perception - UMR8242).
You may qualify if:
- Adults age 18 years and older
- Parkinson's disease
You may not qualify if:
- Other pathology or neurological or psychiatric history
- Known pregnancy or breastfeeding
- Absence of affiliation to social security or universal health coverage (CMU)
- Person under legal protection
- Patient's opposition to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondation Ophtalmologique Adolphe de Rothschild
Paris, 75019, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2016
First Posted
September 9, 2016
Study Start
March 1, 2015
Primary Completion
June 1, 2016
Study Completion
September 1, 2017
Last Updated
August 31, 2018
Record last verified: 2018-08